* Quipt Home Medical Corp QIPT.TO is expected to show a
rise in
quarterly revenue when it reports results on December 16 for
the period ending September 30 2024
* The Wilder Kentucky-based company is expected to report a
3.0% increase in revenue to $64.4 million from $62.52 million a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Quipt Home Medical Corp
is for
a loss of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Quipt Home
Medical Corp is $9.00, above its last closing price of $2.75.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.02 -0.01 -0.04 Missed -166.7
Mar. 31 2024 0.01 0.01 -0.03 Missed -549.8
Dec. 31 2023 0.01 0.00 -0.01 Missed -500
Sep. 30 2023 0.02 0.00 -0.03 Missed -850
Jun. 0.00 0.00 -0.03 Missed -1,696
30 2023 .4
Mar. 31 2023 0.04 0.04 -0.02 Missed -147.1
Dec. 31 2022 0.04 0.05 0.01 Missed -77.8
Sep. 30 2022 0.02 0.02 0.07 Beat 250
This summary was machine generated December 13 at 21:13 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)